OnCo
technologiesTechnologyStandard of care

Radionuclide generators and cold kits

Bench-top devices that 'milk' a short-lived isotope from a long-lived parent, plus vials of ready-to-label ligand. How most hospitals make PSMA and somatostatin PET tracers without a cyclotron.

Ge-68/Ga-68 generators (Eckert & Ziegler GalliaPharm, IRE ELiT Galli Eo, ITG) elute Ga-68 for 6-12 months; Mo-99/Tc-99m generators (Curium, Lantheus, GE) underpin SPECT; kits such as Illuccix and Gozellix (Telix), Locametz (Novartis) and NETSPOT (Novartis/AAA) let a radiopharmacy label PSMA-11 or DOTATATE in minutes. Generator supply shortages (Ge-68 in 2018-19) and kit versus unit-dose economics shape tracer access.

Generic schematic · not to scale · placeholder for the radiopharma front
Receptor (PSMA / SSTR) · Ligand + Lu-177 · β⁻ track ~2 mm, crossfire

How it works

Parent isotope adsorbed on a column decays to the daughter, which is eluted on demand; cold kits contain lyophilised chelator-ligand and buffer for one-step labelling.

Strengths
  • Cyclotron-free access to PET tracers
  • Decentralised, low-cost labelling
Limitations
  • Limited activity per elution (few patients per day)
  • Generator supply concentrated in a few producers
  • Regulatory status of kits varies by country

Latest papers

top
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"Radionuclide generators and cold kits" OR ABSTRACT:"Radionuclide generators and cold kits") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Radionuclide generators and cold kits, not a curated reading list.

Connected

10top